Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMISE: Optimization of Schizophrenia Treatment
NCT01248195Phase 4Completed
- Start
- May 2011
- Primary completion
- Apr 2016
- Modality
- Orthosteric Ligands
- Countries
- 16
01
Overview
A Phase 4 trial of amisulpride, olanzapine, clozapine in schizophrenia, schizophreniform disorder, schizoaffective disorder. Started May 2011; status: completed.
02
Drugs
amisulprideolanzapineclozapine
03
Conditions
schizophreniaschizophreniform disorderschizoaffective disorder
Beyond the preview
Go deeper on NCT01248195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01248195.